Laboratorios Farmaceuticos Rovi SA
(OTCPK:LABFF)
$
90.61
(0%)
Market Cap: 3.26 Bil
Enterprise Value: 3.30 Bil
PE Ratio: 21.78
PB Ratio: 4.26
GF Score: 93/100 
Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation Transcript
Jul 28, 2021 / 01:00PM GMT
Release Date Price:
$67.78
Javier Lopez;Belmonte Encina;Juan Lopez;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO;
Good morning, and welcome, everybody, to this first half 2021 results (inaudible) meeting, which will start in a moment. This is Javier Lopez-Belmonte, ROVI's Vice President and Chief Financial Officer. Please let me introduce ROVI's attendees today, Juan Lopez-Belmonte, Chairman and CEO; Marta Campos, Head of Investor Relations; and myself.
(Operator Instructions) Thank you for your presence here today. And let's now start with the presentation. I give Mr. Juan Lopez-Belmonte the floor.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers